ClinicalTrials.Veeva

Menu
F

Faculdade de Medicina de Botucatu | Unesp

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Baricitinib
Hydroxychloroquine
Remifentanil
Azithromycin
LY3009104
Sufentanil
S42909
JNJ-53718678
Mirikizumab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 11 total trials

A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)

The reason for this study is to see if the study drug baricitinib is safe and effective in participants from 1 year to less than 18 years old with sy...

Enrolling
Systemic Juvenile Idiopathic Arthritis
Drug: Baricitinib
Drug: Tocilizumab

The reason for this study is to see if the study drug baricitinib is safe and effective in the treatment of JIA in participants ages 1 to 17. This st...

Enrolling
Juvenile Idiopathic Arthritis
Drug: Baricitinib

Trial sponsors

Lilly logo
U
I
Janssen (J&J Innovative Medicine) logo
H
U
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems